High throughput sequencing methods, such as Tumor Mutation Burden, somatic detection of BRCA1 and BRCA2 single nucleotide variants and copy number variations that can address patient to targeted therapeutic approaches (13), are strongly influenced by DNA integrity (14, 15). The gene discussed is BRCA2; the disease is neoplasm.